Cancer & Metabolism

Papers
(The TQCC of Cancer & Metabolism is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
The diversity and breadth of cancer cell fatty acid metabolism102
Fructose contributes to the Warburg effect for cancer growth70
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma64
DHODH and cancer: promising prospects to be explored63
Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI61
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer58
Tumor-associated collagen signatures: pushing tumor boundaries36
Pyruvate carboxylase and cancer progression32
Metabolic models predict bacterial passengers in colorectal cancer28
Mitochondrial metabolism as a target for acute myeloid leukemia treatment27
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice25
Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines25
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma24
Modulating pyrimidine ribonucleotide levels for the treatment of cancer23
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer22
Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model22
Metabolite AutoPlotter - an application to process and visualise metabolite data in the web browser21
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism21
Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement21
Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth20
Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3)20
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer18
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma17
Mass spectrometry imaging of L-[ring-13C6]-labeled phenylalanine and tyrosine kinetics in non-small cell lung carcinoma17
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase17
Inflammatory metabolic profile of South African patients with prostate cancer15
Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells15
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover15
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition14
In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells14
Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness14
Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP114
The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer14
0.019912004470825